Programmable Circuit Patent Thicket

Control of the key circuit building blocks may matter almost as much as clinical data in this category. Programmable gene therapies are built from reusable parts such as promoters, sensors, and logic gates, so a company can run into patent friction even when its final drug looks different. Strand is using microRNA sensors and self replicating mRNA circuits in cancer, while Senti has built and partnered around synthetic promoters and NOT gate logic in cell and gene therapy, which makes freedom to operate a real commercialization variable, not a side issue.

• The overlap comes from the fact that circuit companies are often patenting the same kinds of control layers. Senti has publicly described NOT gate systems, logic gated CAR programs, and synthetic promoters, and it has licensed some core rights from the NCI, showing how company IP and academic IP stack on top of each other in one product architecture.
  3 sentibio 4 sentibio 5 globenewswire
• For Strand, the practical risk is not that another company owns all programmable circuits. It is that one claim can cover a sensing step, another can cover a promoter design, and another can cover how the payload is conditionally turned on, forcing licenses, narrower construct design, or slower trial progression as programs move toward pivotal studies.
  1 sacra 4 sentibio
• This pattern has precedent in platform biotech. Strand already describes a future licensing model for its own circuit modules, similar to how CRISPR economics evolved, which is often what happens when a field settles into a shared patent thicket around a small set of foundational inventions.
  1 sacra 6 nih

The field is heading toward a structure where the winners combine product data with a clean rights stack around the circuit components that matter most. As programmable therapies move from elegant lab constructs into approved drugs, patent estates around sensing, targeting, and conditional expression will become part of the product itself, shaping who can partner broadly, scale fastest, and keep the most downstream economics.